Bicara Therapeutics (BCAX) Q1 2025 Earnings

27MarConfirmed
Q4 2024
Q1 2025
-1.6
-1.18
-0.75
-0.33

Details

Expected EPS
-0.3292
Actual EPS
-0.39
Surprise EPS
-0.06
Surprise Percent
+18.47%

Description

Bicara Therapeutics (BCAX) has reported earnings of -0.39 per share for Q1 2025.

0 Comments

Share your thoughts